Peptides are everywhere in the longevity world—but which ones actually have evidence behind them?

GLP-1 medications, growth-hormone secretagogues, BPC-157, GHK-Cu, thymosin peptides, MOTS-c, Epitalon, Humanin, mitochondrial peptides, and dozens of other compounds are increasingly promoted for fat loss, muscle preservation, recovery, energy, skin, sleep, hormones, and healthy aging.

But the word peptide does not automatically mean safe, proven, natural, or appropriate.

The Longevity Peptide Handbook gives readers a practical framework for understanding peptide medicine without confusing promising biology with established clinical benefit.

Inside, you will explore:

What peptides are and how they influence human physiology
What scientists actually mean by lifespan, healthspan, and biological aging
The hallmarks of aging and where peptide research may fit
GLP-1 receptor agonists, tirzepatide, retatrutide, and metabolic therapies
Sermorelin, tesamorelin, ipamorelin, CJC-1295, GHRP-2, and GHRP-6
BPC-157, TB-500, thymosin alpha-1, and GHK-Cu
Epitalon, MOTS-c, Humanin, and mitochondrial therapeutics
Kisspeptin, PT-141, melanocortin peptides, and hormone-related compounds
Peptides promoted for muscle, recovery, skin, energy, sleep, and metabolism
How to separate animal research from meaningful human evidence
How peptide marketing can exaggerate scientific findings
Approved medicines versus off-label, compounded, investigational, and unapproved products
How to evaluate peptide clinics, telehealth providers, and pharmacies
Why injectable products require special attention to sterility, potency, and manufacturing
Side effects, interactions, metabolic concerns, and other safety questions
How to read clinical trials and certificates of analysis
Decision guides for fat loss, muscle preservation, energy, skin, recovery, sleep, hormone function, and longevity
The future of senolytic, mitochondrial, brain-aging, muscle-aging, and AI-designed peptides
A practical peptide encyclopedia covering major compounds individually

The book uses a consistent four-part framework: molecule, evidence, product, and patient. Readers are encouraged to ask what a peptide actually targets, what human evidence supports the claim, how the product is regulated and manufactured, and whether the intervention makes sense for a real person with real risks.

Experimental compounds are not presented as equivalent to established medicines. Each major peptide is examined according to mechanism, human evidence, safety concerns, regulatory status, and where longevity marketing may go beyond the data.

The book also places peptides where they belong: inside a larger longevity strategy that includes muscle, cardiovascular fitness, nutrition, sleep, metabolic health, disease prevention, and measurement of meaningful outcomes.

The goal is not to find the most exciting peptide. It is to understand which claims are supported, which remain experimental, and which questions should be asked before treatment is considered.

For readers interested in peptide therapy, healthy aging, GLP-1 medicines, body composition, longevity clinics, mitochondrial medicine, recovery, hormone health, and emerging anti-aging science, The Longevity Peptide Handbook provides a comprehensive map of a rapidly changing field.

Follow the evidence. Understand the risks. Make better-informed decisions.